Latest news
Loading news…
Gilead Sciences
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Foster City, California, United States Founded 1987 10001+ employees For Profit
Gilead Sciences develops and markets biopharmaceutical therapies, focusing on antiviral, oncology, and inflammatory diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
26
Investments
74
18 exits
Monthly Visits
Available in Pro Contacts
9,640
Ticker
GILD
NASDAQ
Patents
1,692
1,238 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- GILD
- Exchange
- NASDAQ
- IPO date
- Jan 22, 1992
- Raised at IPO
- $86M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 130
- Mobile apps
- 1
- Active products
- 41
- Patents granted
- 1,692
- Trademarks
- 1,238
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $639M
Investor Activity
- Investments
- 74
- Lead investments
- 44
- Portfolio orgs
- 58
- Diversity investments
- 20
- Exits
- 18
- Exits via IPO
- 14
Company Info
- Founded
- 1987
- Employees
- 10001+
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- Sub-organizations
- 6
- News articles
- 4,450
- Events
- 1
- HQ
- Foster City, California, United States
- Region
- San Francisco Bay Area, Silicon Valley, West Coast
- Exit date
- Jan 22, 1992
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- -0.4
- Trend (30d)
- -2.3
- Trend (90d)
- -2
- Last leadership hire
- Feb 10, 2026
- Last layoff mention
- May 5, 2026
Investments by Gilead Sciences
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Gilead Sciences
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Gilead Sciences
Executive Chairman of the Board of Directors
Independent Director
Chief Executive Officer
Member of the Board of Directors
Director, Investor Relations
Head of Global Patient Solutions for Medical Affairs
Mobile Product Management
Senior Vice President of Public Affairs
Senior Mobile Architect & Senior Technical Delivery Manager
Senior Vice President of Corporate Development and Alliance Management
Senior Vice President, Clinical Data Science
Vice President, Biomarker Sciences
Senior Manager of Business Strategy and Operations
Senior Director, Global Supply Chain
SVP - Oncology Clinical Development, Therapeutic Area Head
Sr. Manager, IT Portfolio
Executive Director, Clinical Operations Oncology
Sr Director
EVP, Head of Pharmaceutical Development & Manufacturing
EVP, General Counsel, Legal and Compliance
Vice President - Region Head Latin America
Senior Research Scientist
Senior Director
International Lead – Global Events, Medical Affairs
9,640
professional contacts at Gilead Sciences
Contact execs at Gilead Sciences →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Gilead Sciences
Loading news…
FAQs about Gilead Sciences
People who checked this page also checked these
Sectors Gilead Sciences invests & acquires in
Browse the full Acquirezy directory.